Počet záznamů: 1
FUNDAMANT: an interventional 72-week phase 1 follow-up study of AADvac1, an active immunotherapy against tau protein pathology in Alzheimer's disease
- 1.Novák, P., Schmidt, R., Kontseková, E., Kováčech, B., Smolek, T., Katina, S., Fialová, L., Prčina, M., Parrak, V., Dal-Bianco, P., Brunner, M., Staffen, W., Rainer, M., Ondruš, M., Ropele, S., Smíšek, M., Sivak, R., Žilka, N., Winblad, B., Novák, M. FUNDAMANT: an interventional 72-week phase 1 follow-up study of AADvac1, an active immunotherapy against tau protein pathology in Alzheimer's disease. Alzheimers Research & Therapy. 2018, 10), 108. E-ISSN 1758-9193. Dostupné z: doi: 10.1186/s13195-018-0436-1
Počet záznamů: 1